Micro Diagnostic Chains

Chandan Healthcare Ltd.

CHANDAN

Market Cap
₹598 Cr.
P/E
22.11

Chandan Healthcare Ltd.

  • Chandan Healthcare
  • Aspira Pathlab&Diagn
  • Nephro Care India

FAQs on Chandan Healthcare Ltd. Shareprice

Chandan Healthcare has given lower returns compared to its competitors.
Chandan Healthcare has grown at ~8.85% over the last 1yrs while peers have grown at a median rate of 51.0%

Chandan Healthcare is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Chandan Healthcare is 22.11, while 3 year average PE is 27.57.
Also latest EV/EBITDA of Chandan Healthcare is 14.94 while 3yr average is 13.81.

View FAQ's On Business

Growth Table

  • Chandan Healthcare Ltd.
  • Aspira Pathlab&Diagn
  • Nephro Care India

Balance Sheet

  • Chandan Healthcare Ltd.
  • Aspira Pathlab&Diagn
  • Nephro Care India

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Chandan Healthcare Ltd.
  • Aspira Pathlab&Diagn
  • Nephro Care India

Cash Flow

  • Chandan Healthcare Ltd.
  • Aspira Pathlab&Diagn
  • Nephro Care India

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Chandan Healthcare Ltd.
  • Aspira Pathlab&Diagn
  • Nephro Care India

Quarterly Results

  • Chandan Healthcare Ltd.
  • Aspira Pathlab&Diagn
  • Nephro Care India

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Chandan Healthcare Ltd. Financials

Balance sheet of Chandan Healthcare is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Chandan Healthcare is increasing.
Latest net debt of Chandan Healthcare is ₹50.16 Crs as of Mar-26.
This is greater than Mar-25 when it was ₹36.4 Crs.

Yes, profit is increasing.
The profit of Chandan Healthcare is ₹22.77 Crs for TTM, ₹22.17 Crs for Mar 2025 and ₹16.28 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Chandan Healthcare latest dividend payout ratio is 18.43% and 3yr average dividend payout ratio is 38.91%

Companies resources are allocated to majorly productive assets like Plant & Machinery

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech